Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11356-020-12200-1 http://scihub22266oqcxt.onion/10.1007/s11356-020-12200-1 33447984!7808930!33447984     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Environ+Sci+Pollut+Res+Int 2021 ; 28 (30): 40431-40444 Nephropedia Template TP {{tp|p=33447984|t=2021. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications |pdf=|usr=}}{{33447984}} gab.com Text Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications JO: Environ Sci Pollut Res Int http://www.kidney.de/pget.php?&tw=1&pmid=33447984 #FOAvip The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected the entire world with its infectious spread and mortality rate. The severe cases of coronavirus disease 2019 (COVID-19) are characterized by hypoxia and acute respiratory distress syndrome. In the absence of any specific treatment, just the preventive and supportive care options are available. Therefore, much focus is given to assess the available therapeutic options not only to avoid acute respiratory failure and hypoxia but also to reduce the viral load to control the severity of the disease. The antimalarial drug hydroxychloroquine (HCQ) is among the much-discussed drugs for the treatment and management of COVID-19 patients. This article reviews the therapeutic potential of HCQ in the treatment of COVID-19 based on the available in vitro and clinical evidence, current status of registered HCQ-based clinical trials investigating therapeutic options for COVID-19, and environmental implications of HCQ. Twit Text FOAVip Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications ????Environ Sci Pollut Res Int http://www.kidney.de/pget.php?&tw=1&pmid=33447984 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33447984 #FOAvip English Wikipedia <ref>{{Cite pmid|33447984}}</ref> Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications #MMPMID33447984 Kumar R; Sharma A; Srivastava JK; Siddiqui MH; Uddin MS; Aleya L Environ Sci Pollut Res Int 2021[Aug]; 28 (30): 40431-40444 PMID33447984show ga The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected the entire world with its infectious spread and mortality rate. The severe cases of coronavirus disease 2019 (COVID-19) are characterized by hypoxia and acute respiratory distress syndrome. In the absence of any specific treatment, just the preventive and supportive care options are available. Therefore, much focus is given to assess the available therapeutic options not only to avoid acute respiratory failure and hypoxia but also to reduce the viral load to control the severity of the disease. The antimalarial drug hydroxychloroquine (HCQ) is among the much-discussed drugs for the treatment and management of COVID-19 patients. This article reviews the therapeutic potential of HCQ in the treatment of COVID-19 based on the available in vitro and clinical evidence, current status of registered HCQ-based clinical trials investigating therapeutic options for COVID-19, and environmental implications of HCQ. |*COVID-19 Drug Treatment[MESH] |*Coronavirus Infections/drug therapy[MESH] |Antiviral Agents[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH]Hydroxychloroquine in COVID-19: therapeutic promises, current status, (epmc).pdf DeepDyve Pubget Overpricing